Anika Therapeutics | Fremdkapital

Aktienkurs
14.15
Täglich Wechseln
-0.17 -1.19%
Monatlich
41.22%
Jährlich
-17.73%
Q1 Prognose
13.92




Fremdkapital Veränderung Datum
Abbott USD 9.9B 1.7B 2025-12
Agenus USD 23.6M 448K 2025-09
Agios Pharmaceuticals USD 1.06M 0 2022-09
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 538.1M 323.22M 2025-12
Enanta Pharmaceuticals USD 0 0 2024-12
Halozyme Therapeutics USD 2.14B 1.34B 2025-12
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 540.96M 1.24M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
Intrexon USD 0 198.67M 2024-06
J&J USD 39.44B 30M 2025-12
Karyopharm Therapeutics USD -0.93 0.67 2024-12
Ligand Pharmaceuticals USD 445.49M 445.44M 2025-09
MacroGenics USD 70.26M 4K 2025-09
Merit Medical Systems USD 734.04M 1.12M 2025-12
Rigel Pharmaceuticals USD 0 0 2024-09
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 15.72B 2.45B 2025-12
Smith & Nephew USD 3.3B 22M 2025-12
Stryker USD 14.86B 14M 2025-12
Surmodics USD 29.55M 30K 2024-09
Veracyte USD 0 0 2025-03
Xencor USD 76.48M 11.29M 2025-12
Zimmer Biomet Holdings USD 6.93B 580.6M 2025-12


Anika Therapeutics Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.